Case Report | Open Access
Sumesh Kumar Dash1, Lipika Jena1 , Rajashree Panigrahy1, Suneeta Sahu2 and Santosh Singh3
1Deptment of Microbiology, IMS & SUM Hospital, Siksha O Anusandhan (Deemed to be) University, Bhubaneswar, Odisha, India.
2Microbiology & Hospital Infection Control, Apollo Hospital, Bhubaneswar, Odisha, India.
3Deptment of Medicine, IMS & SUM Hospital, Siksha O Anusandhan (Deemed to be) University, Bhubaneswar, Odisha, India.
Article Number: 7661 | © The Author(s). 2022
J Pure Appl Microbiol. 2022;16(4):2949-2953. https://doi.org/10.22207/JPAM.16.4.12
Received: 07 March 2022 | Accepted: 22 July 2022 | Published online: 06 October 2022
Issue online: December 2022
Abstract

Brucellosis is a rising veterinary and human health problem in India. It may manifest with a varied multisystem clinical presentation. In our case patient was of 72 years male with a complaint of abdominal pain for 2 months following COVID-19 infection. He was a known case of CAD (coronary artery disease) post PTCA status, on regular follow up & treatment. Patient had post COVID pulmonary fibrosis. When the patient admitted in our hospital with above mentioned complaints, necessary investigations along with blood culture by automated method was sent and patient was started on empirical doxycycline along with other symptomatic treatment. As the patient was not very sick and was reluctant to stay in hospital during the COVID-19 situation, he was discharged on request with a treatment and follow up plan. Blood culture was found to be positive for Brucella melitensis. When we got the blood culture report the patient was contacted telephonically and started Rifampicin along with Doxycycline for 6 weeks.

Keywords

Brucellosis, COVID-19, Human Health, Blood Culture, Zoonotic Disease

Introduction

Brucellosis is a re-emerging and remaining to be the commonest infectious zoonotic disease, which accounts for more than 5 lakh cases1 in a year. In spite that brucellosis and its modes of transmission known to us for more than 100 years, still a worldwide issue, specially in developing countries. In India and its neighbour countries, animal and human brucellosis are endemic in some parts till now.2-5 Worldwide more than 5 lakh brucellosis cases were reported annually.6

The disease continues to be a concern in countries like India, where environment favors the infection to spread in human being. Among the Brucella species Brucella melitensis is the most virulent & species to worry in India. Brucella abortus pathogenic to cattle. Many studies reveal that human brucellosis is not rare in India. Two studies done by Mathur in 1964 and 1968 enlighten that 8.5% seroprevalence of brucellosis in persons who comes interact frequently with not only infected cattle but also goats & sheep. In Gujarat, in 1986 Panjarathinam and Jhala documented. 8.5% occurrence of brucella agglutinins in human cases. The common ways by which Brucella spread from animals to human are through consuming raw dairy products, touching body fluids and blood of infected animals, inhaling contaminated air.

Brucellosis is a multisystem, wide-spectrum disease with non-specific symptoms which occurs within 2 weeks to 3 months after inoculation. The common symptoms and signs are fever, chills, sweats, headaches fatigue, malaise, myalgia, arthralgia, and weight loss.7 The diagnosing a case is thought-provoking because multiorgan, multisystemic and sometimes resembles infectious and noninfectious diseases.8 It is invariably misdiagnosed, due to varied and confusing presentation.9 The patients also having gastrointestinal symptom as abdominal pain (19%),10 diarrhea (6% – 16%),11 constipation anorexia, nausea, vomiting.12 Ileal involvement also seen in brucellosis case.13-15 Systemic symptoms are more common than gastrointestinal manifestations of brucellosis in human. Doctors should be aware to these rare manifestations as early recognition of brucellosis and proper treatment in time will decrease the morbidity and mortality.

The causative organism Brucellae belongs to a–2 subdivision of proteobacteria. They are Gram-negative, facultative intracellular coccobacilli or short rods, partially acid fast, aerobic, free-living, soil-dwelling organism that mostly infecting dairy animals. In infected hosts, the bacteria located intracellularly, mostly within the reticuloendothelial system.16 They are positive for oxidase, catalase, urease and nitrate reductase. The genome consists of two circular chromosomes of 2.1 Mb and 1.5 Mb except B.suis biovar 3, which bears a single chromosome of 3.1 Mb. There are six species of Brucella and 4 of which pathogenic to human. B. abortus specially infects cattle, B. melitensis infects sheep and goats, B. suis pigs and B. canis dogs. B. melitensis being the species of concern.

Diagnosis of Brucellaeis a challenging one. Blood culture gives definite proof of organism but less sensitive and specific than Lysis centrifugation and blood clot culture techniques re.17 Other diagnostic methods include Antigen detection, PCR, Antibody detection, Agglutination tests. ELISA Newer rapid assays: Brucella IgM and IgG lateral flow18 and latex agglutination assays.19

Being facultative intracellular, Brucellae are inaccessible to antibiotics. The treatment recommended by the World Health Organization for acute brucellosis in adults is rifampicin 600 to 900 mg and doxycycline 100mg BD for 6wks.20 The combination of intramuscular streptomycin & tetracycline minimises the relapses.21

Case Presentation
A 72 years Male patient presented with abdominal pain for 2 months admitted in gastroenterology department in our hospital. Pain abdomen was the only symptom and the pain was localized to umbilical region, non radiating, not associated with food intake and there was no history fever, vomiting. Patient was a known case of CAD post PTCA status from 2018, on regular follow up & treatment. Patient had history of SARS-CoV-2 infection followed by pulmonary fibrosis. Due to pain abdomen following SARS-CoV-2 infection patient had visited multiple hospitals and had followed different treatments. As he had history of SARS-CoV-2 along with pulmonary fibrosis everywhere he was investigated as a post COVID case with complications. Due to nonresolution of symptoms after 2 months when the patient admitted in our hospital, he was investigated broadly with all necessary investigations along with blood culture. Patient was started with empirical antibiotic along with doxycycline and other symptomatic treatment and was reluctant for prolonged hospitalization due to the COVID scenario. So, he was discharged on request with a proper treatment and follow-up plan. Blood culture sample was flagged positive by BACT/ALERT and was subcultured on blood agar and MacConkey agar. Colony from blood agar was put in VITEK 2 for identification and sensitivity which was came positive for Brucella melitensis. After getting the culture report patient was contacted telephonically and prescribed p.o. rifampicin OD with doxycycline BD for 6 weeks. As brucellosis is notifiable disease it was also informed to the concerned authority as per protocol. Patient was found to be recovered on subsequent follow up. Other test reports are as follows (Table).

Table (1):
Laboratory examinations.

Hemogram Lipid Profile
Hb 12.8 gm/dl Triglyceride 115 mg/dl
TRBC 5,130,000 /µl VLDL 90 mg/dl
TLC 10,090 /µl LDL 29 mg/dl
TPC 1,73,000 /µl HDL 38 mg/dl
DC [N/L/M/E/B](in %) 67.5/25/5.3/1.9/0.3 Total cholesterol 23 mg/dl
RFT Viral Markers
S. Urea 11 mg/dl Anti HCV NR
S. Creatinine 0.66 mg/dl HIV NR
S. Na+ 127 mEq/L HBsAg NR
S. K 3.8 mEq/L HBeAg NR
LFT ENZYME
S.Bilirubin (Total) 0.26 mg/dl S. Lipase 62.0 IU/l
S.Bilirubin (Direct) 0.14 mg/dl S. Amylase 203.00 IU/L
AST/SGOT 14.50 IU/L  
ALT/SGPT 8.20 IU/L FBS 114 mg/dl
ALP 108.00 IU/L TSH 5.31 micro Iu / ml
S. Protein (Total) 6.79 gm/dl S. Calcium 8.21 mg/dl
S. Albumin 4.08 gm/dl URINE (R/M) NAD
S. Globulin 2.71 gm/dl  

N.B-Hb-Haemoglobin, TRBC- Total red blood cell count, TLC- Total leucocyte count, TPC-Total platelet count, DC-Differential count, N-Neutrophile, L-Lymphpcyte, M-Monocyte, E-Eosinophile, B-Basophile, RFT –Renal function test, Na-sodium, K-potassium, LFT-Liver function test, AST–Aspartate transaminase, ALT-Alanine transaminase, SGOT-Serum glutamic oxaloacetic transaminase, SGPT-Serum glutamic pyruvic transaminase, ALP-Alkaline phosphatase, VLDL-Very low density lipoprotein, LDL-Low density lipoprotein, HDL- High density lipoprotein, HCV–Hepatitis c virus, HIV-Human immunodeficiency virus, HBsAg-Hepatitis b surface antigen, HBeAg-Hepatitis b envelop antigen. FBS–Fasting blood sugar, TSH–Thyroid stimulating hormone, NR-Nonreactive, NAD–No abnormality detected

USG abdomen & pelvis revealed mild fatty liver, bilateral isoechoic kidneys & prostatomegaly. Patient was started on iv fluids, iv antibiotics and other supportive measures. Cardiology opinion was taken for CAD post PTCA status & advise followed, CT abdomen angiogram revealed diffuse atherosclerotic wall calcification in abdominal aorta extending into bilateral common & internal iliac arteries. Cardiology review was taken & advised for continuation of anti-platelets. USG abdomen & pelvis: mild fatty liver, b/l isoechoic kidneys & prostatomegaly CECT abdomen angiogram: diffuse atherosclerotic wall calcification in abdominal aorta extending into b/l common & internal iliac arteries.

RESULTS AND DISCUSSION

With global distribution, Brucellosis is an important re-emerging zoonotic disease. As cattle are an important reservoir, transmission from these animals have raised important epidemiological issues. In developing countries, it is still a serious community problem due to drinking of unpasteurised animal product and relapsing nature of the disease when proper treatment is followed. melitensis recently accounts for most recorded brucellosis cases worldwide. The manifestation may be a multiorgan or a multisystemic and sometimes it is asymptomatic or mimic several infectious and noninfectious diseases.8,22 So, for its diversity range of spectrum, diagnosis of brucellosis can be challenging. Most of the time lack of proper history, alertness of clinicians, routine serological surveillance in endemic areas is the burden for determining the actual prevalence of human brucellosis. Clinician expand their differential diagnosis about the diseases and diagnose with newer rapid, sensitive, and specific testing methodologies, appropriate regimen is need to overcome the morbidity and mortality of brucellosis. In our case uncommon and mild clinical symptoms, doubtful history of exposure to animals or consuming animal products along with post SARS-CoV-2 infection state of the patient lead to a diagnostic dilemma. In spite of misleading factors in this covid pandemic era a high level of suspicion is always necessary for accurate and early diagnosis of brucellosis. Gastrointestinal manifestations also one of the presenting symptoms of the diseases. So proper teamwork of clinicians and microbiologist are essential for early correct diagnose and treatment regimen of protean human brucellosis.23

CONCLUSION

Being a mimicker of a number of diseases due to its multisystem involvement, clinicians should keep in mind a differential diagnosis of Brucellosis while encountering a case of pain abdomen as early diagnosis and treatment is the key to decrease the morbidity.

Declarations

ACKNOWLEDGMENTS
The authors would like to thank Chairman of Siksha O Anusandhan (deemed to be) University Prof. M.R Nayak for providing all the support during the work. The authors are also thankful to the students of the IMS & SUM Hospital for participating in this study.

CONFLICT OF INTEREST
The authors declare that there is no conflict of interest.

AUTHORS’ CONTRIBUTION
LJ conceived and designed the study. SSa provided research materials. SKD collected and organized data. RP analyzed and interpreted data. SSi wrote the initial and final draft of the article. All authors read and approved the final manuscript for publication.

FUNDING
None.

DATA AVAILABILITY
All datasets generated or analyzed during this study are included in the manuscript.

ETHICS STATEMENT
Not available.

INFORMED CONSENT
Written informed consent was obtained from the participants before enrolling in the study.

References
  1. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. 2006;6(2):91-99.
    Crossref
  2. Akhtar R, Chaudhry ZI, Shakoori AR, Ahmad MU, Aslam A. Comparative efficacy of conventional diagnostic methods and evaluation of polymerase chain reaction for the diagnosis of bovine brucellosis. Vet World. 2010;3(2):53-6.
  3. Ghodasara SN, Roy A, Bhanderi BB. Comparison of Rose Bengal plate agglutination, standard tube agglutination and indirect ELISA tests for detection of Brucella antibodies in cows and buffaloes. Vet World. 2010;3(2):61-4.
  4. Zhong Z, Yu S, Wang X, et al. Human brucellosis in the People’s Republic of China during 2005-2010. Int J Infect Dis. 2013;17(5):e289-e292.
    Crossref
  5. Priyantha MA. Identification of biovars of Brucella abortus in aborted cattle and buffaloes herd in Sri Lanka. Vet World. 2011;4(12):542.
  6. Dean AS, Crump L, Greter H, Schelling E, Zinsstag J. Global burden of human brucellosis: a systematic review of disease frequency. PLoS neglected tropical diseases. 2012;6(10):e1865.
  7. Kochar DK, Gupta BK, Gupta A, Kalla A, Nayak KC, Purohit SK. Hospital-based case series of 175 cases of serologically confirmed brucellosis in Bikaner. J Assoc Physicians India. 2007;55:271-275.
  8. Araj GF. Human brucellosis: a classical infectious disease with persistent diagnostic challenges. Clin Lab Sci. 1999;12(4):207-212.
  9. Corbel MJ. Brucellosis: an overview. Emerg Infect Dis. 1997;3(2):213-221.
    Crossref
  10. Dean AS, Crump L, Greter H, Hattendorf J, Schelling E, Zinsstag J. Clinical manifestations of human brucellosis: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2012;6(12):e1929.
    Crossref
  11. Ablin J, Mevorach D, Eliakim R. Brucellosis and the gastrointestinal tract. The odd couple. J Clin Gastroenterol. 1997;24(1):25-29.
    Crossref
  12. Salih SB, Alothman A. Acute brucellosis presenting as gastroenteritis: case report. Infect Dis (Auckl). 2013;6:35-37. Published 2013 Apr 10.
    Crossref
  13. Petrella R, Young EJ. Acute brucella ileitis. Am J Gastroenterol. 1988;83(1):80-82.
  14. Wang M, Zhu Q, Yang Q, et al. Intestinal brucellosis associated with celiac artery and superior mesenteric artery stenosis and with ileum mucosa and submucosa thickening: A case report. Medicine (Baltimore). 2017;96(2):e5893.
    Crossref
  15. Akhvlediani T, Bautista CT, Garuchava N, et al. Epidemiological and Clinical Features of Brucellosis in the Country of Georgia. PLoS One. 2017;12(1):e0170376. Published 2017 Jan 20.
    Crossref
  16. Shaqinah N, Mazlina M, Zamri-Saad M, Hazilawati H, Jasni S. In vitro penetration and survival of Brucella melitensis in lymphocytic cells of goats. J. Vet. Res. 2012;16(3):104-10.
  17. Mantur BG, Mangalgi SS. Evaluation of conventional castaneda and lysis centrifugation blood culture techniques for diagnosis of human brucellosis. J Clin Microbiol. 2004;42(9):4327-4328.
    Crossref
  18. Smits HL, Abdoel TH, Solera J, Clavijo E, Diaz R. Immunochromatographic Brucella-specific immunoglobulin M and G lateral flow assays for rapid serodiagnosis of human brucellosis. Clin Diagn Lab Immunol. 2003;10(6):1141-1146.
    Crossref
  19. Abdoel TH, Smits HL. Rapid latex agglutination test for the serodiagnosis of human brucellosis. Diagn Microbiol Infect Dis. 2007;57(2):123-128.
    Crossref
  20. Joint FA, World Health Organization. Joint FAO/WHO Expert Committee on Brucellosis [meeting held in Geneva from 12 to 19 November 1985]: sixth report. World Health Organization; 1986.
  21. Ariza J, Gudiol F, Pallarés R, Rufí G, Fernández-Viladrich P. Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis. Antimicrob Agents Chemother. 1985;28(4):548-551.
    Crossref
  22. 22. Colmenero JD, Reguera JM, Martos F, et al. Complications associated with Brucella melitensis infection: a study of 530 cases [published correction appears in Medicine (Baltimore) 1997 Mar;76(2):139]. Medicine (Baltimore). 1996;75(4):195-211.
    Crossref
  23. Mantur BG, Amarnath SK, Shinde RS. Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol. 2007;25(3):188-202.
    Crossref

Article Metrics

Article View: 241

Share This Article

© The Author(s) 2022. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.